The cutis laxa syndromes are multisystem disorders that share loose redundant inelastic and wrinkled skin as a common hallmark clinical feature. The underlying molecular defects are heterogeneous and 13 different genes have been involved until now, all of them being implicated in elastic fiber assembly. We provide here molecular and clinical characterization of three unrelated patients with a very rare phenotype associating cutis laxa, facial dysmorphism, severe growth retardation, hyperostotic skeletal dysplasia, and intellectual disability. This disorder called Lenz-Majewski syndrome (LMS) is associated with gain of function mutations in PTDSS1, encoding an enzyme involved in phospholipid biosynthesis. This report illustrates that LMS is an unequivocal cutis laxa syndrome and expands the clinical and molecular spectrum of this group of disorders. In the neonatal period, brachydactyly and facial dysmorphism are two early distinctive signs, later followed by intellectual disability and hyperostotic skeletal dysplasia with severe dwarfism allowing differentiation of this condition from other cutis laxa phenotypes. Further studies are needed to understand the link between PTDSS1 and extra cellular matrix assembly.
| INTRODUCTION
Congenital cutis laxa (CL) is a rare and heterogeneous condition characterized by over-folded skin giving a prematurely aged appearance from birth onwards. Based on its accompanying features, it usually falls within a clinical spectrum that to date includes thirteen delineated conditions corresponding to FBLN5-, FBLN4-, ELN-, ATP6V0A2-, PYCR1-, ALDH18A1-, RIN2-, LTBP4-, ATP6V1E1-, and ATP6V1A-related cutis laxa, gerodermia osteodysplastica, occipital horn syndrome, and arterial tortuosity syndrome (OMIM 219100, 614437, 130160, 219200, 614438, 219150, 610222, 613177, 108746, 607027, 231070, 304150, 208050) (Callewaert & Urban, 2016; Loeys, De Paepe, & Urban, 2011; Vanakker, Callewaert, Malfait, & Coucke, 2015; Van Damme et al., 2017; Van Maldergem, Dobyns, & Kornak, 2009; Van Maldergem & Loeys, 2009) . The underlying molecular defects in CL perturb extracellular matrix assembly and/or homeostasis and involve all steps in elastic fiber formation. An activation of TGFβ signaling, which plays a crucial role in soft connective tissue and skeletal development, has been observed in several types of CL (MacFarlane, Haupt, Dietz, & Shore, 2017; Renard et al., 2010 ).
We describe here three patients with Lenz-Majewski syndrome (LMS; OMIM 612792), which is a very rare hyperostotic skeletal dysplasia with intellectual disability (Lenz & Majewski, 1974) , belonging to the bona fide congenital CL group of syndromes. LMS is caused by activating de novo heterozygous mutations in PTDSS1, encoding phosphatidylserine synthase 1 (PSS1). It is not understood at present why deregulated PSS1 activity in the endoplasmic reticulum can result in skeletal dysplasia and CL (Sousa et al., 2014) . The skin abnormality is particularly striking in the three patients described here. One patient was initially referred to the Cutis Laxa Study Group for advice and has been briefly reported in the seminal paper describing the molecular basis of LMS (Sousa et al., 2014) . The other two patients described for the first time here, are the eighth and ninth LMS patients reported with a defined PTDSS1 mutation. 
| Patient 1
This girl was born at term after an uneventful pregnancy to parents aged 27 and 30 years, originating from Bohemia in the Czech Republic. Her birth weight was 2700 g (−1.8 SD), length was 44 cm (−3.5 SD), and OFC was 32 cm (−3SD). Over-folded skin affecting the whole body, prominent veins, joint laxity, brachydactyly, and lipodystrophy of buttocks were present. A large fontanelle and a distinct facial dysmorphism including broad forehead, telecanthus, wide mouth, long philtrum, and thin vermilion of the lips were also observed (Figure 1 ). Her growth and development were severely delayed. At 9 years, she could not walk without assistance, her height was 84 cm (−9 SD), weight was 10.1 kg (−8.7 SD), and OFC was 45.5 cm (−5 DS). She has no speech. Her skin appeared thin, with wrinkles distributed regularly over her whole body.
Tooth eruption was delayed. Changes in her facial gestalt were obvious: prognathism, prominent eyes, coarseness, and a progeroid appearance.
Sparse hair, oligodontia, and kyphoscoliosis were also noted. Over the years, fading of her CL was seen. Brain MRI showed diffuse cortical atrophy, enlarged lateral ventricles, and apparent pituitary hypoplasia.
Bone X-rays showed structural changes to all bones, with sclerosis mainly in the skull and vertebra, hip dislocation, turricephaly, mildly delayed ossification and thickness of the long bone diaphyses.
| Patient 2
Patient 2 was a male born at 41 weeks of gestation, with a birth weight of 2310g (−2.2 SD), a length of 46 cm (−3 SD), and OFC of 32 cm (−3 SD).
Widespread thin skin wrinkles were present all over the body and the skin was translucent. Facial dysmorphism comprising broad forehead, prominent eyes, telecanthus, medial crease of the philtrum, thin vermilion of the lips, and retrognathia was observed (Figure 2 ). His developmental milestones were severely delayed: he walked without assistance at 40 months and learned only a few words. Generalized seizures without fever started at 4 years and were responsive to antiepileptic drugs. Fontanelle closure was delayed until 9 years. When examined in adulthood, a coarse long face, tall and broad chin with 
| DISCUSSION
In the present report of three patients with congenital CL, we provide evidence for a fourteenth etiology underlying this cutaneous phenotype (Table 1) . Gain of function mutations in PTDSS1 underlie LMS, which is an extremely rare syndrome with only 16 sporadic cases reported in the literature between 1969 and 2015 (Lenz & Majewski, 1974; Majewski, 2000; Sousa et al., 2014; Tamhankar et al., 2015; Whyte et al., 2015) . Clinical features of LMS include craniotubular hyperostosis, loose skin, progeroid appearance, marked growth failure, and moderate to severe intellectual disability. Loose atrophic skin or CL has been described in all reported patients. reported by Sousa et al. (2014) . Since then, two further LMS patients have been described, with mutations in exon 7 (Tamhankar et al., 2015; Whyte et al., 2015) . This means that LMS is a very rare disease with our description here of the novel c.284G>T; (p.Arg95Leu), and c.806C>T; (p. Pro269Leu) PTDSS1 mutation representing only the eighth and ninth patients with confirmed molecular diagnoses reported so far. Many of the reported mutations are recurrent at specific amino acid positions and all cluster in non-transmembrane domains, which are found on the luminal FIGURE 6 Patient 3 at birth. Prominent wrinkling of the skin in the neck, forehead, chin, and right thigh can be seen. The patient has a long philtrum with a medial crease, thin vermilion of the lips, telecanthus, sagging cheeks, and retrognathia which are part of the distinctive facial dysmorphism. Moderate brachydactyly of all fingers was noted, particularly affecting the 4th and 5th rays, also with interdigital webbing and clinodactyly. [Color figure can be viewed at wileyonlinelibrary.com] side of the endoplasmic reticulum/mitochondria-associated membranes.
They also locate at or nearby to amino acid residues in which mutations were previously demonstrated to be activating in a study by Ohsawa et al. (2004) who studied PSS1 activity following systematic alanine mutagenesis in Chinese Hamster ovary (CHO) cells. Enzymatic studies in LMS patient fibroblasts confirmed similar findings, demonstrating increased synthesis of PS associated with resistance to PS feedback inhibition (Sousa et al., 2014) . The c.284G>T (p.Arg95Leu) mutation is located in exon 3 and also corresponds to a distinct cytosolic non-transmembrane domain. Interestingly, this mutation affects the same arginine residue (Arg-95) that is altered in a CHO cell mutant named "29" isolated from CHO-K1 cells in which the biochemical activating effect was first demonstrated (Hasegawa, Kuge, Nishijima, & Akamatsu, 1989; Kuge, Hasegawa, Saito, & Nishijima, 1998; Ohsawa, Nishijima, & Kuge, 2004) . These earlier observations therefore strongly suggest that this mutation is also likely to cause a gain-of function, as has been described for previously reported mutations (Sousa et al., 2014) . Table 1 ).
Most reported patients did not survive until adulthood. Majewski, In our patient 2, at 26 years of age, we notably observe enlargement of the mandible determining an elongated appearance of the face and a wide nasal root, which appears highly set. In contrast, telecanthus, strabismus, prominent eyes and veins were present from childhood on.
An interesting point is the regressive course of CL over the years similar to what has been observed in most other subtypes of CL.
Although it might be difficult to draw general statements concerning handling and follow-up of such a very rare condition with only nine PTDSS1 mutation confirmed patients known until now, the follow-up of such patients should comply with general recommendations concerning severely to profoundly disabled individuals.
Nonetheless, special attention should be paid to their progressive skeletal dysplasia, and particularly to disproportionate growth of the mandible and the corresponding impairment of feeding, teeth malocclusion and pain. Consequently periodic consultations with the orthopedic surgeon and the dentist or the maxillofacial surgeon are recommended.
Skeletal deformities evolve similarly to those of a lysosomal storage disorder, progressing into dwarfism with facial coarsening over two decades. The marked prognathism displayed by our patient 2 resembles that observed in sclerosteosis (OMIM 269500), van Buchem disease (OMIM 239100), or craniodiaphyseal dysplasia (OMIM 122860), the most severe and lethal form of craniotubular dysplasia, which are all caused by SOST deficiency (Kim et al., 2011) . Although no functional link between SOST and PTDSS1 has yet been established, the phenotypic overlap suggests activation of Wnt signaling pathway, which normally promotes bone formation, and underlies high bone mass disorders (MacFarlane et al., 2017 ).
In conclusion, we report here three patients with LMS and heterozygous mutations in PTDSS1. We describe an adult phenotype and two novel PTDSS1 mutations. We suggest that LMS should be considered in the differential diagnosis of a newborn with CL.
Brachydactyly and facial dysmorphism should guide the correct diagnosis at this period. While the CL improves with age, in contrast to other CL-associated syndromes, LMS evolves to a severe skeletal dysplasia with major growth failure alongside with severe intellectual disability. Therefore this syndrome can be easily distinguishable from other forms of CL at later stages.
